Literature DB >> 6886977

Dose-dependent elimination of propranolol and its major metabolites in humans.

B M Silber, N H Holford, S Riegelman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6886977     DOI: 10.1002/jps.2600720703

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  10 in total

Review 1.  Nonlinear pharmacokinetics: clinical Implications.

Authors:  T M Ludden
Journal:  Clin Pharmacokinet       Date:  1991-06       Impact factor: 6.447

2.  Application of gastrointestinal simulation for extensions for biowaivers of highly permeable compounds.

Authors:  Marija Tubic-Grozdanis; Michael B Bolger; Peter Langguth
Journal:  AAPS J       Date:  2008-04-02       Impact factor: 4.009

Review 3.  Clinical significance of genetic influences on cardiovascular drug metabolism.

Authors:  L Arcavi; N L Benowitz
Journal:  Cardiovasc Drugs Ther       Date:  1993-06       Impact factor: 3.727

4.  The relationship between debrisoquine oxidation phenotype and the pharmacokinetics and pharmacodynamics of propranolol.

Authors:  M S Lennard; P R Jackson; S Freestone; G T Tucker; L E Ramsay; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

Review 5.  Theophylline. Pooled Michaelis-Menten parameters (Vmax and Km) and implications.

Authors:  J G Wagner
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

6.  Time-dependent inhibition of human drug metabolizing cytochromes P450 by tricyclic antidepressants.

Authors:  Thomas M Polasek; John O Miners
Journal:  Br J Clin Pharmacol       Date:  2007-07-27       Impact factor: 4.335

7.  Nonlinear formation of propranolol metabolites in dogs after portacaval transpositions.

Authors:  M W Lo; S M Pond; D J Effeney; B M Silber; S Riegelman; T N Tozer
Journal:  J Pharmacokinet Biopharm       Date:  1984-08

8.  Propranolol pharmacokinetics and pharmacodynamics after single doses and at steady-state.

Authors:  R L Lalonde; J A Pieper; R J Straka; M B Bottorff; D M Mirvis
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

9.  Accumulation kinetics of propranolol in the rat: comparison of Michaelis-Menten-mediated clearance and clearance changes consistent with the "altered enzyme hypothesis".

Authors:  C Weber; K Stoeckel; D Lalka
Journal:  Pharm Res       Date:  1994-03       Impact factor: 4.200

10.  PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol.

Authors:  David G Levitt
Journal:  BMC Clin Pharmacol       Date:  2002-08-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.